Laurel Wealth Advisors (North Carolina)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-29
Closed -$2.77K 259
2025
Q4
$2.77K Buy
+29
New +$2.84K ﹤0.01% 591
2025
Q2
Sell
-12
Closed -$1.21K 259
2025
Q1
$1.21K Buy
+12
New +$1.21K ﹤0.01% 621

Other funds holding BSX

Laurel Wealth Advisors (North Carolina)'s BSX Position: Q1 2026 in Review

Laurel Wealth Advisors (North Carolina) sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 29 shares — an estimated $2.77K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in BSX in Q1 2025 and held it in 2 quarters. The position peaked at $2.77K in Q4 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Laurel Wealth Advisors (North Carolina) reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 29 Boston Scientific shares in Q1 2026, an estimated $2.77K.
  • Laurel Wealth Advisors (North Carolina) first reported a position in Boston Scientific in Q1 2025 and held it in 2 quarters.
  • Laurel Wealth Advisors (North Carolina)'s Boston Scientific position peaked at $2.77K in Q4 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q1 2026, filed 13 May 2026.